GO:0071139 resolution of DNA recombination intermediates: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0071139 (resolution of DNA recombination intermediates) is the biological process that cleaves and rejoins recombination intermediates such as Holliday junctions to produce two intact DNA molecules with exchanged genetic material.
Resolution is executed by structure-selective nucleases and helicase-topoisomerase complexes, including GEN1, BLM, and BRCA1-BARD1, which act on single and double Holliday junctions.
Meiotic recombination depends on timely resolution to form crossovers, and its dysregulation is linked to human infertility such as non-obstructive azoospermia.
Defects in resolution factors cause hypersensitivity to DNA interstrand crosslinks and genome instability, with FIRRM/C1orf112 identified as a mediator of homologous recombination intermediate resolution.
Resolution is regulated by cell-cycle kinases and phosphatases, such as Cdc14, which controls crossover formation during meiosis.
Experimental dissection of resolution uses defined Holliday junction substrates, yeast mitotic genetics, and CRISPR-engineered human cell models.

Description

Resolution of DNA recombination intermediates (GO:0071139) is the final, decisive step of homologous recombination, in which branched DNA structures such as Holliday junctions are cleaved and rejoined to yield two separate, intact DNA molecules with exchanged genetic material. Without this step, recombination would stall, leaving persistent joint molecules that block chromosome segregation and threaten genome stability. The process is therefore central to DNA repair, meiosis, and the maintenance of genomic integrity across eukaryotes. Researchers study GO:0071139 because its failure or misregulation is associated with cancer predisposition, infertility, and sensitivity to DNA-damaging agents. The reaction is carried out by dedicated nucleases and helicase-topoisomerase complexes that recognize branched DNA and catalyze strand cleavage and religation with high precision. This article synthesizes the QuickGO definition and verified literature to explain the mechanism, key genes, disease links, and experimental methods used to investigate resolution of DNA recombination intermediates.

resolution of DNA recombination intermediates At A Glance

GO ID GO:0071139
GO term resolution of DNA recombination intermediates
Ontology biological_process
Synonym resolution of recombination intermediates
Definition The cleavage and rejoining of intermediates, such as Holliday junctions, formed during DNA recombination to produce two intact molecules in which genetic material has been exchanged.
Major function Completion of homologous recombination by processing Holliday junctions and other joint DNA molecules into resolved products.
Key enzymes Structure-selective nucleases (e.g., GEN1) and helicase-topoisomerase complexes (e.g., BLM, BRCA1-BARD1).
Biological context Meiosis, mitotic DNA repair, and response to DNA interstrand crosslinks.
Disease relevance Genome instability, cancer predisposition, and non-obstructive azoospermia.

What Is GO:0071139?

According to the Gene Ontology, GO:0071139 (resolution of DNA recombination intermediates) is the biological process in which intermediates formed during DNA recombination, such as Holliday junctions, are cleaved and rejoined to produce two intact molecules in which genetic material has been exchanged. In other words, it is the enzymatic processing of branched recombination structures into resolved DNA products, ensuring that recombination is completed rather than left as unresolved joint molecules.

Why Is resolution of DNA recombination intermediates Important in Cell Biology?

Resolution of DNA recombination intermediates is essential because it converts transient recombination intermediates into stable, segregated DNA molecules, thereby completing homologous recombination and safeguarding chromosome integrity. Failure of this process leads to persistent joint molecules that can cause chromosome mis-segregation, DNA damage sensitivity, and genome instability, which are hallmarks of cancer and other diseases. In meiosis, resolution determines crossover formation and is required for proper chromosome segregation and fertility. Thus, understanding GO:0071139 provides mechanistic insight into DNA repair, reproductive biology, and potential therapeutic targets.
Completes homologous recombination by resolving Holliday junctions into intact DNA molecules.
Prevents persistent joint molecules that block chromosome segregation and cause genome instability.
Required for meiotic crossover formation and proper chromosome segregation.
Mediates cellular tolerance to DNA interstrand crosslinks through factors such as FIRRM/C1orf112.
Dysregulation is linked to cancer predisposition and chemosensitivity.
Defects in meiotic resolution are associated with non-obstructive azoospermia.
Provides a target for understanding and overcoming DNA repair inhibitor resistance.
Serves as a paradigm for structure-selective nuclease and helicase-topoisomerase mechanisms.
Experimental models in yeast and human cells enable mechanistic dissection.
CRISPR-engineered cell models allow causal testing of resolution genes.

What Happens During resolution of DNA recombination intermediates?

Formation of Holliday junctions and joint molecules
In simple terms: Recombination first creates crossed DNA strands called Holliday junctions that must be untangled.
During homologous recombination, strand invasion and DNA synthesis generate branched intermediates, including single and double Holliday junctions, that physically link the recombining DNA molecules. These joint molecules are the substrates for resolution and must be processed to allow chromosome separation.
Nucleolytic cleavage by structure-selective nucleases
In simple terms: Specialized enzymes cut the crossed DNA strands at specific points.
Structure-selective nucleases such as GEN1 recognize and cleave Holliday junctions, resolving both single and double Holliday junction intermediates in vitro and in cells. The cleavage generates nicked or linear products that can be rejoined, completing the exchange of genetic material.
Helicase-topoisomerase-mediated dissolution
In simple terms: A helicase and a topoisomerase work together to unwind and untangle the joint DNA without cutting both strands.
The BLM helicase in complex with topoisomerase IIIα and BLAP75/RMI1 dissolves double Holliday junctions by a strand-passage mechanism that avoids crossover formation. BRCA1-BARD1 coordinates with BLM to provide complementary resolution activities, ensuring efficient processing of joint DNA molecules.
Regulation by cell-cycle kinases and phosphatases
In simple terms: Timing of resolution is controlled by enzymes that add or remove phosphate groups.
The Cdc14 phosphatase controls resolution of recombination intermediates and crossover formation during meiosis, linking cell-cycle progression to the completion of recombination. This regulation ensures that resolution occurs at the appropriate stage and that crossovers are properly distributed.
Resolution in response to DNA interstrand crosslinks
In simple terms: When DNA strands are chemically linked, resolution factors help to process the damage.
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks, and its loss leads to sensitivity to crosslinking agents. This highlights a specialized role for resolution in repair of complex DNA lesions.

Key Genes Involved in GO:0071139 resolution of DNA recombination intermediates

The following genes and proteins are central to the resolution of DNA recombination intermediates, as supported by the verified literature.
GeneMajor RoleResearch Relevance
GEN1Structure-selective nuclease that cleaves Holliday junctionsMechanistic studies of junction cleavage and resolution
BLMHelicase that dissolves double Holliday junctions with topoisomerase IIIαBloom syndrome and cancer biology; resolution assays
BRCA1Coordinates with BLM for complementary resolution mechanismsBreast/ovarian cancer predisposition; DNA repair
BARD1Partners with BRCA1 in resolution coordinationCancer susceptibility and repair pathway studies
FIRRM/C1orf112Mediates resolution of homologous recombination intermediates in response to interstrand crosslinksCrosslink repair and chemosensitivity
CDC14Phosphatase controlling resolution and crossover formation during meiosisMeiotic regulation and cell-cycle studies
TOP3ATopoisomerase in the BLM complex for dissolutionDissolution mechanism and genome stability
RMI1Component of the BLM-topoisomerase complexDissolution assays and complex assembly
RMI2Component of the BLM-topoisomerase complexDissolution assays and complex assembly
MUS81Structure-selective nuclease involved in resolutionResolution pathway redundancy
SLX1Structure-selective nuclease involved in resolutionResolution pathway redundancy
SLX4Scaffold for structure-selective nucleasesResolution complex assembly
EXO1Exonuclease that processes recombination intermediatesEnd resection and resolution
SGS1Yeast helicase ortholog of BLMYeast mitotic resolution models
RAD51Recombinase that forms joint moleculesRecombination initiation and resolution
DMC1Meiosis-specific recombinaseMeiotic recombination and infertility
MLH1Mismatch repair protein involved in crossover formationMeiotic crossover and infertility
MLH3Mismatch repair protein involved in crossover formationMeiotic crossover and infertility

How Is resolution of DNA recombination intermediates Regulated?

Resolution of DNA recombination intermediates is regulated at multiple levels. The Cdc14 phosphatase controls resolution and crossover formation during meiosis, linking cell-cycle progression to the completion of recombination. BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution, indicating that regulation involves protein-protein interactions and post-translational modifications. In response to DNA interstrand crosslinks, FIRRM/C1orf112 mediates resolution, suggesting lesion-specific regulatory pathways. These examples show that resolution is not a constitutive housekeeping step but is subject to cell-cycle and damage-specific control.

resolution of DNA recombination intermediates and Human Disease

GeneDisease / BiologyPotential Experimental Model
BLMBloom syndrome; cancer predispositionBLM knockout cell lines for resolution assays
BRCA1Breast/ovarian cancer; DNA repair deficiencyBRCA1 knockout or point-mutant cells
BARD1Cancer susceptibility; repair coordinationBARD1 knockout cells
FIRRM/C1orf112Interstrand crosslink sensitivity; genome instabilityFIRRM knockout cells treated with crosslinkers
CDC14Meiotic failure; infertilityCdc14 mutant yeast or mouse models
Cancer and genome instability
Defects in resolution factors such as BLM and BRCA1-BARD1 lead to impaired processing of joint DNA molecules, causing genome instability and cancer predisposition. Loss of FIRRM/C1orf112-mediated resolution confers sensitivity to DNA interstrand crosslinks, a phenotype relevant to chemotherapy response. Thus, resolution of DNA recombination intermediates is a determinant of DNA repair capacity and chemosensitivity in cancer cells.
Meiotic failure and infertility
Meiotic recombination requires timely resolution of intermediates to form crossovers and ensure proper chromosome segregation. Dysregulation of resolution, including through Cdc14 phosphatase control, can impair crossover formation and is associated with human infertility such as non-obstructive azoospermia. These findings link GO:0071139 to reproductive disorders.
Bloom syndrome and related disorders
BLM helicase is a key resolution factor, and its dysfunction causes Bloom syndrome, characterized by genome instability and cancer predisposition. The coordinated action of BLM with BRCA1-BARD1 underscores how resolution defects can manifest as inherited disorders.

From resolution of DNA recombination intermediates-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of GEN1 impair Holliday junction resolution?GEN1 knockout human cell lines
How does BLM coordinate with BRCA1-BARD1?BLM/BRCA1 double knockout or point-mutant cells
What is the role of FIRRM in crosslink repair?FIRRM knockout cells with crosslinker treatment
How does Cdc14 regulate meiotic resolution?Cdc14 point-mutant yeast or mouse models
Can resolution be monitored in real time?Tagged knock-in of resolution factors for imaging
Does overexpression of a resolution factor alter crossover frequency?Overexpression cell lines and meiotic assays

How to Study the resolution of DNA recombination intermediates Process

MethodWhat It MeasuresTypical Application
Holliday junction cleavage assayNuclease activity on junction substratesGEN1 and structure-selective nuclease studies
Gel electrophoresis of joint moleculesResolution of recombination intermediatesIn vitro and cell-based resolution assays
Yeast mitotic recombination assaysNucleolytic resolution in vivoMechanistic studies in yeast
Crossover and fertility assaysMeiotic resolution outcomesInfertility and meiosis research
CRISPR knockout sensitivity assaysCrosslinker and DNA damage responseFIRRM and repair factor studies
Co-immunoprecipitationProtein complex formationBLM-BRCA1-BARD1 interactions
Live-cell imaging of tagged factorsReal-time resolution dynamicsResolution factor localization
Phosphatase mutant analysisRegulation of resolution timingCdc14 control of meiosis
Holliday junction resolution assays
In vitro resolution assays use defined Holliday junction DNA substrates incubated with purified enzymes or cell extracts, followed by gel electrophoresis to detect cleavage products. These assays allow mechanistic dissection of single and double Holliday junction processing by GEN1 and other nucleases.
Yeast mitotic genetics
Yeast mitotic cells provide a powerful system to study nucleolytic resolution of recombination intermediates, using mutants and physical assays to track joint molecule processing. This approach has defined roles for structure-selective nucleases and helicases in resolution.
Meiotic recombination analysis
Meiotic recombination can be studied by monitoring crossover formation, chromosome segregation, and fertility in model organisms, linking resolution to reproductive outcomes. Cdc14 phosphatase mutants are used to dissect the regulation of resolution during meiosis.
CRISPR-engineered human cell models
Knockout, point-mutation, and knock-in human cell lines enable causal testing of resolution genes in DNA repair and crosslink sensitivity. These models are combined with damage sensitivity assays and imaging to quantify resolution efficiency.

How CRISPR Can Be Used to Study GO:0071139 resolution of DNA recombination intermediates

Knockout

CRISPR knockout of resolution genes such as BLM, BRCA1, or FIRRM allows researchers to test their requirement for processing recombination intermediates and sensitivity to DNA-damaging agents. These models reveal pathway redundancy and synthetic lethality.

Point Mutation

Point mutations can be introduced into catalytic residues of nucleases like GEN1 or helicase domains of BLM to separate enzymatic activities from scaffolding functions. Such models help define which activities are essential for resolution.

Knock-in

Tagged knock-in of resolution factors enables visualization and biochemical isolation of complexes from native chromatin contexts. This approach is useful for tracking Holliday junction processing in live cells.

Overexpression

Overexpression of resolution factors can be used to test whether increased dosage alters crossover frequency or resolution efficiency. Such models complement loss-of-function studies to establish causality.

How EDITGENE Supports resolution of DNA recombination intermediates Research

Researchers studying resolution of DNA recombination intermediates-related genes often need to determine whether a candidate gene is causally involved in processing Holliday junctions, responding to DNA damage, or influencing meiotic outcomes. EDITGENE provides the CRISPR tools and cell models required to move from correlation to mechanism.
Contact EDITGENE today to design your custom CRISPR model for resolution of DNA recombination intermediates research.

Frequently Asked Questions About resolution of DNA recombination intermediates

It is the biological process GO:0071139 in which intermediates such as Holliday junctions are cleaved and rejoined to produce two intact DNA molecules with exchanged genetic material.
Key genes include GEN1, BLM, BRCA1, BARD1, FIRRM/C1orf112, CDC14, and structure-selective nucleases such as MUS81 and SLX1.
It completes homologous recombination, prevents chromosome mis-segregation, and is required for meiosis and DNA crosslink repair.
It is regulated by cell-cycle phosphatases such as Cdc14 and by coordinated protein interactions involving BLM and BRCA1-BARD1.
Defects are linked to cancer predisposition, genome instability, Bloom syndrome, and non-obstructive azoospermia.
Common methods include Holliday junction cleavage assays, yeast mitotic genetics, meiotic crossover assays, and CRISPR-engineered human cell models.
GEN1 is a structure-selective nuclease that cleaves single and double Holliday junctions to resolve recombination intermediates.
BLM, in complex with topoisomerase IIIα and RMI proteins, dissolves double Holliday junctions and coordinates with BRCA1-BARD1 for complementary resolution.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of resolution genes in DNA repair and meiosis.
The GO ID is GO:0071139, a biological process term.

Conclusion

Resolution of DNA recombination intermediates (GO:0071139) is a fundamental biological process that completes homologous recombination by cleaving and rejoining Holliday junctions and related joint molecules. Its mechanistic dissection has revealed key roles for GEN1, BLM, BRCA1-BARD1, FIRRM/C1orf112, and Cdc14, linking resolution to genome stability, meiosis, and disease. Continued research using CRISPR-engineered models and biochemical assays will further clarify how resolution is regulated and how its dysfunction contributes to cancer and infertility.

References

  1. 1. West SC et al.. 2015. Resolution of Recombination Intermediates: Mechanisms and Regulation.. Cold Spring Harb Symp Quant Biol 80:103-9 PMID: 26370409
  2. 2. Tsukada K et al.. 2024. BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution.. Mol Cell 84(4):640-658.e10 PMID: 38266639
  3. 3. Xie C et al.. 2022. Meiotic recombination: insights into its mechanisms and its role in human reproduction with a special focus on non-obstructive azoospermia.. Hum Reprod Update 28(6):763-797 PMID: 35613017
  4. 4. Mazouzi A et al.. 2023. FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks.. Sci Adv 9(22):eadf4409 PMID: 37256941
  5. 5. Shah Punatar R et al.. 2018. Preparation and Resolution of Holliday Junction DNA Recombination Intermediates.. Methods Enzymol 600:569-590 PMID: 29458775
  6. 6. Alonso-Ramos P et al.. 2021. The Cdc14 Phosphatase Controls Resolution of Recombination Intermediates and Crossover Formation during Meiosis.. Int J Mol Sci 22(18) PMID: 34575966
  7. 7. Shah Punatar R et al.. 2017. Resolution of single and double Holliday junction recombination intermediates by GEN1.. Proc Natl Acad Sci U S A 114(3):443-450 PMID: 28049850
  8. 8. Talhaoui I et al.. 2016. The nucleolytic resolution of recombination intermediates in yeast mitotic cells.. FEMS Yeast Res 16(6) PMID: 27509904
Contact Us
*
*
*
*
How did you hear about us: